| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |